Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV001049871 | SCV001213945 | uncertain significance | Koolen-de Vries syndrome | 2022-11-08 | criteria provided, single submitter | clinical testing | Until the location of this sequence change can be resolved, the clinical significance of this variant remains uncertain. It has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KANSL1 protein function. ClinVar contains an entry for this variant (Variation ID: 846545). This variant has not been reported in the literature in individuals with KANSL1-related conditions. This variant is present in population databases (rs760506954, gnomAD 0.003%). This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 101 of the KANSL1 protein (p.Val101Ile). Due to the possible presence of a polymorphic segmental duplication, the location of the variant could not be unambiguously resolved. Variants with ambiguous mapping are still reported relative to the KANSL1 transcript. |
| Fulgent Genetics, |
RCV001049871 | SCV002800751 | uncertain significance | Koolen-de Vries syndrome | 2021-09-23 | criteria provided, single submitter | clinical testing |